Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
22,552,672
-
Shares change
-
+1,830,496
-
Total reported value, excl. options
-
$1,508,022,257
-
Value change
-
+$123,782,702
-
Put/Call ratio
-
2.9%
-
Number of buys
-
117
-
Number of sells
-
72
-
Price
-
$66.87
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2023
As of 30 Sep 2023 DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) had 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,552,672 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Royal Bank of Canada, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Robeco Institutional Asset Management B.V., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Man Group plc, MORGAN STANLEY, and GQG Partners LLC.
This table shows 212 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.